EMO.F EM Systems Co. Ltd
- Market cap
- EUR 212M
- P/E
- 25.5x
- P/B
- 1.87x
- ROE
- 10.2%
- Dividend yield
- 4.82%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is EMO.F undervalued?
Graham numberEMO.F trades 45.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
EM Systems Co. Ltd fundamental analysis
No fundamental analysis for EM Systems Co. Ltd yet.
EM Systems Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About EM Systems Co. Ltd
EM Systems Co., Ltd., together with its subsidiaries, develops, sells, and maintains various IT systems for pharmacies, clinics, and care/welfare other business in Japan. The company operates through Dispensing Systems Business, Medical Systems Business, Nursing Care/Welfare System Business, and Other Business segments. It develops and sells IT systems for pharmacies, such as medical fee receipt computers and electronic medication record systems; IT systems for clinics, incl…
Full company profileEM Systems Co. Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
EM Systems Co. Ltd annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 13.7B | 14.0B | 13.1B | 14.0B | - | 14.4B | 16.9B | 20.4B | 24.8B | 23.7B | 21.6B |
| Gross Profit | 7.61B | 7.88B | 7.41B | 7.05B | - | 7.09B | 8.28B | 9.92B | 13.6B | 11.9B | 10.9B |
| Operating Income | 2.60B | 3.07B | 2.63B | 1.59B | - | 1.88B | 2.41B | 2.34B | 4.47B | 3.69B | 2.82B |
| EBITDA | - | 4.19B | 3.58B | 2.76B | - | 3.57B | 3.76B | 4.22B | 5.27B | 4.92B | 3.20B |
| Net Income | 2.12B | 2.37B | 1.97B | 1.39B | - | 1.83B | 1.89B | 1.96B | 2.43B | 2.45B | 2.03B |
| EPS | 30 | 33 | 28 | 20 | - | 26 | 27 | 28 | 35 | 35 | 29 |
| Balance Sheet | |||||||||||
| Total Assets | 21.3B | 21.9B | 22.4B | 23.4B | - | 24.8B | 26.3B | 29.4B | 31.7B | 27.5B | 26.8B |
| Total Liabilities | 7.29B | 5.84B | 5.73B | 5.75B | - | 5.98B | 6.85B | 8.82B | 11.1B | 7.08B | 6.78B |
| Shareholders' Equity | 14.1B | 16.1B | 16.6B | 17.7B | - | 18.8B | 19.5B | 20.5B | 20.6B | 20.4B | 20.0B |
| Cash & Short-term Investments | 7.90B | 8.53B | 7.49B | 8.77B | - | 8.29B | 8.88B | 9.44B | 11.9B | 7.85B | 6.58B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 2.08B | 2.32B | 1.85B | 2.30B | 589M | 1.71B | 2.47B | 1.58B | 5.76B | 2.01B | - |
| Capital Expenditure | 323M | 11.0M | 254M | 256M | 497M | 116M | 65.0M | 756M | 755M | 1.38B | 0.00 |
| Free Cash Flow | - | 2.01B | 622M | 1.18B | - | 1.12B | 2.02B | 828M | 5.00B | 627M | - |
| Ratios | |||||||||||
| ROE | 15.0% | 14.8% | 11.9% | 7.9% | - | 9.7% | 9.7% | 9.6% | 11.8% | 12.0% | 10.2% |
| ROA | 9.9% | 10.8% | 8.8% | 5.9% | - | 7.4% | 7.2% | 6.7% | 7.7% | 8.9% | 7.6% |
| Net Profit Margin | 15.5% | 17.0% | 15.0% | 9.9% | - | 12.7% | 11.2% | 9.6% | 9.8% | 10.4% | 9.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
EM Systems Co. Ltd dividends
- Dividend yield
- 4.82%
- Forward dividend
- 0.15 EUR
- Payout ratio
- 121.2%
- Ex-dividend date
- Dec 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 2.97B | 43 | 121.2% |
| 2025 | JPY 1.12B | 16 | 46.3% |
| 2024 | JPY 1.06B | 15 | 54.0% |
| 2023 | JPY 781M | 11 | 41.3% |
| 2022 | JPY 714M | 10 | 39.0% |
| 2021 | JPY 943M | - | - |
| 2020 | EUR 668M | 9.39 | 48.0% |
| 2019 | EUR 708M | 10 | 35.9% |
| 2018 | EUR 636M | 8.93 | 26.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Dec 27, 2019.
Who owns EM Systems Co. Ltd
- Insiders 54.69%
- Institutions 10.56%
- Public & others 34.75%
- Shares outstanding 69.3M
- Free float 29.9M
EM Systems Co. Ltd company profile
- Company name
- EM Systems Co. Ltd
- Ticker
- EMO.F
- ISIN
- JP3130200003
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 858
- Fiscal year end
- March
- Address
- Shin-Osaka Brick Building, Osaka, Japan, 532-0003
- Phone
- 81 50 5530 5619
- Website
- emsystems.co.jp
About EM Systems Co. Ltd
EM Systems Co., Ltd., together with its subsidiaries, develops, sells, and maintains various IT systems for pharmacies, clinics, and care/welfare other business in Japan. The company operates through Dispensing Systems Business, Medical Systems Business, Nursing Care/Welfare System Business, and Other Business segments. It develops and sells IT systems for pharmacies, such as medical fee receipt computers and electronic medication record systems; IT systems for clinics, including medical accounting and electronic medical record systems; and office processing systems for care/welfare providers. In addition, the company offers staffing, pharmacy management, cashless, and development and operation of statistical information analysis services. EM Systems Co., Ltd. was incorporated in 1980 and is based in Osaka, Japan.
EM Systems Co. Ltd management
9- Mr. Kenji OishiExecutive Chairman · born 1958
- Mr. Hiromasa KunimitsuPresident, CEO, Executive Officer & Representative Director · born 1974
- Mr. Kozo KunimitsuChief Advisor & Director · born 1945
- Ms. Megumi SekiSenior Executive Officer, GM of Management Headquarters & Director · born 1972
- Mr. Hirokazu KawanoharaExecutive Officer & GM of Integrated Quality Control HQ
- Ryusuke MoritaExecutive Officer, Head of Dispensing Company & Business Mgmt HQ
- Koji TogawaExecutive Officer & Head of Medical Sales Division - Sales Headquarters
- Daigo KobayashiSenior Executive Officer & Head of Corp Strategy HQ
- . KashiharaExecutive - Corporate Strategy Department